BRIEF published on 08/09/2024 at 16:12, 3 months 13 days ago Cairn Homes Plc: Block Listing Interim Review Regulatory Announcement Block Listing SAYE Plan Cairn Homes Share Options
PRESS RELEASE published on 08/09/2024 at 16:07, 3 months 13 days ago Cairn Homes Plc: Block listing Interim Review Cairn Homes Plc updates block listing interim review for share option and SAYE plan, showing balance of unallotted securities and recent activity. Contact: Tara Grimley Cairn Homes Plc Block Listing SAYE Plan Share Option Tara Grimley
BRIEF published on 08/09/2024 at 14:27, 3 months 13 days ago FIL Limited Adjusts Stake in Cairn Homes Plc Voting Rights Cairn Homes Financial Instruments FIL Limited Central Bank Of Ireland
PRESS RELEASE published on 08/09/2024 at 14:22, 3 months 13 days ago Cairn Homes Plc: Holding(s) in Company Cairn Homes Plc: Notification of major holdings by FIL Limited on 07th August 2024. Threshhold crossed downwards to 9.10% voting rights and 2.97% through financial instruments Voting Rights Cairn Homes Plc Major Holdings Notification FIL Limited
BRIEF published on 08/09/2024 at 08:05, 3 months 14 days ago Cairn Homes Plc: Transaction in Own Shares Ordinary Shares Share Buyback Cairn Homes Market Regulation Stock Repurchase
PRESS RELEASE published on 08/09/2024 at 08:00, 3 months 14 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchased 196,355 of its ordinary shares on Euronext Dublin and LSE through Goodbody. Shares to be cancelled. Details of transactions provided London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Goodbody Stockbrokers
BRIEF published on 08/08/2024 at 08:05, 3 months 15 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Repurchase Euronext Dublin Cairn Homes Buyback Programme
PRESS RELEASE published on 08/08/2024 at 08:00, 3 months 15 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 200,000 of its own ordinary shares on Euronext Dublin and London Stock Exchange, as part of a buyback program London Stock Exchange Ordinary Shares Cairn Homes Plc Euronext Dublin Buyback Program
BRIEF published on 08/07/2024 at 08:05, 3 months 16 days ago Cairn Homes Plc: Share Buyback Transaction London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Goodbody Stockbrokers
PRESS RELEASE published on 08/07/2024 at 08:00, 3 months 16 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchased 100,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange, as part of its share buyback program London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Goodbody Stockbrokers
Published on 11/22/2024 at 23:55, 12 hours 44 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 13 hours 9 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 13 hours 34 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 14 hours 9 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 18 hours 24 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 18 hours 45 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 19 hours 43 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 20 hours 39 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 17 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
